Protease activated receptor-1 is down regulated by levonorgestrel in endometrial stromal cells

Angiogenesis

Volumn 5, Issue 1-2, 2002, Pages 93-98

  Hague, S ^a,b   Oehler, M K ^a,b   MacKenzie, I Z ^a   Bicknell, R ^b   Rees, M C P ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Expression arrays; Progestogens; Protease activated receptor 1; Stromal cells; Thrombin

Indexed keywords

GESTAGEN; LEVONORGESTREL; POLYADENYLATED RNA; PROGESTERONE; PROTEINASE ACTIVATED RECEPTOR 1; THROMBIN;

ADULT; ARTICLE; BLEEDING; CLINICAL OBSERVATION; CONTROLLED STUDY; DECIDUALIZATION; ENDOMETRIUM ATROPHY; ENDOMETRIUM CELL; ESTROGEN BINDING; FEMALE; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; HORMONAL REGULATION; HORMONE RECEPTOR INTERACTION; HORMONE SUBSTITUTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MENSTRUATION; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; RNA PROBE; WESTERN BLOTTING;

DOWN-REGULATION; ENDOMETRIUM; FEMALE; HUMANS; LEVONORGESTREL; PROGESTERONE; PROGESTERONE CONGENERS; PROGESTINS; RECEPTOR, PAR-1; RECEPTORS, THROMBIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STROMAL CELLS;

RICKETTSIA SP. PAR;

EID: 0036941838     PISSN: 09696970     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1021510723157     Document Type: Article

References (34)

1. Lahteenmaki P, Rauramo I, Backman T. The levonorgestrel intrauterine system in contraception. Steroids 2000; 65: 693-7.
2. Riphagen FE. Intrauterine applications of progestins in hormone replacement therapy: A review. Climateric 2000; 3: 199-211.
3. Nilsson CG, Haukkamaa M, Vierola H, Luukkainen T. Tissue concentrations of levonorgestrel in women using a levonorgestrel-releasing IUD. Clin Endocrinol (Oxf) 1982; 17: 529-36.
4. Silverberg SG, Haukkamaa M, Arko H et al. Endometrial morphology during long-term use of levonorgestrel-releasing intrauterine devices. Int J Gynecol Pathol 1986; 5: 235-41.
5. Salmi A, Pakarinen P, Peltola AM et al. The effect of intrauterine levonorgestrel use on the expression of c-JUN, oestrogen receptors, progesterone receptors and Ki-67 in human endometrium. Mol Hum Reprod 1998; 4: 1110-5.
6. Luo H, Zhu P, Xu R et al. Inhibition of DNA synthesis in isolated human endometrial cells by a levonorgestrel-releasing intrauterine device. Anal Quant Cytol Histol 1999; 21: 409-12.
7. Critchley HO, Wang H, Kelly RW et al. Progestin receptor isoforms and prostaglandin dehydrogenase in the endometrium of women using a levonorgestrel-releasing intrauterine system. Hum Reprod 1998; 13: 1210-1.
8. Rutanen EM, Salmi A, Nyman T. mRNA expression of insulin-like growth factor-I (IGF-I) is suppressed and those of IGF-II and IGF-binding protein-1 are constantly expressed in the endometrium during use of an intrauterine levonorgestrel system. Mol Hum Reprod 1997; 3: 749-54.
9. Pekonen F, Nyman T, Lahteenmaki P et al. Intrauterine progestin induces continuous insulin-like growth factor-binding protein-1 production in the human endometrium. J Clin Endocrinol Metab 1992; 75: 660-4.
10. Murphy LJ, Ghahary A. Uterine insulin-like growth factor-1: Regulation of expression and its role in estrogen-induced uterine proliferation. Endocr Rev 1990; 11: 443-53.
11. Rutanen E, Hurskainen R, Finne P, Nokelainen K. Induction of endometrial plasminogen activator-inhibitor 1: A possible mechanism contributing to the effect of intrauterine levonorgestrel in the treatment of menorrhagia. Fertil Steril 2000, 73: 1020-4.
12. Satyaswaroop PG, Bressler RS, de la Pena MM et al. Isolation and culture of human endometrial glands. J Clin Endocrinol Metab 1979; 48: 639-41.
13. Fernandez-Shaw S, Shorter SC, Naish CE et al. Isolation and purification of human endometrial stromal and glandular cells using immunomagnetic microspheres. Hum Reprod 1992; 7: 156-61.
14. Wells M. Female genital tract. In Underwood JC (ed): General and Systemic Pathology, Edinburgh: Churchill Livingstone 1996; 551-84.
15. Nierodzik ML, Bain RM, Liu LX et al. Presence of the seven transmembrane thrombin receptor on human tumour cells: Effect of activation on tumour adhesion to platelets and tumor tyrosine phosphorylation. Br J Haematol 1996; 92: 452-7.
16. Macfarlane SR, Seatter MJ, Kanke T. Proteinase-activated receptors. Pharmacol Rev 2001; 53: 245-82.
17. Arena CS, Quirk SM, Zhang YQ et al. Rat uterine stromal cells: Thrombin receptor and growth stimulation by thrombin. Endocrinology 1996; 137: 3744-9.
18. Lockwood CJ, Krikun G, Aigner S et al. Effects of thrombin on steroid-modulated cultured endometrial stromal cell fibrinolytic potential. J Clin Endocrinol Metab 1996; 81: 107-12.
19. Haslinger B, Mandl-Weber S, Sitter T. Thrombin suppresses matrix metalloproteinase 2 activity and increases tissue inhibitor of metalloproteinase 1 synthesis in cultured human peritoneal mesothelial cells. Perit Dial Int 2000; 20: 778-83.
20. Fernandez-Patron C, Martinez-Cuesta MA, Salas E et al. Differential regulation of platelet aggregation by matrix metalloproteinases-9 and -2. Thromb Haemost 1999; 82: 1730-5.
21. Klein-Soyer C, Duhamel-Clerin E, Ravanat C et al. PF4 inhibits thrombin-stimulated MMP-1 and MMP-3 metalloproteinase expression in human vascular endothelial cells. C R Acad Sci III 1997; 320: 857-68.
22. Hampton AL, Nie G, Salamonsen LA. Progesterone analogues similarly modulate endometrial matrix metalloproteinase-1 and matrix metalloproteinase-3 and their inhibitor in a model for long-term contraceptive effects. Mol Hum Reprod 1999; 5: 365-71.
23. Osteen KG, Keller NR, Feltus FA et al. Paracrine regulation of matrix metalloproteinase expression in the normal human endometrium. Gynecol Obstet Invest 1999; 48(Suppl 1): 2-13.
24. Marbaix E, Vekemans M, Galant C et al. Circulating sex hormones and endometrial stromelysin-1 (matrix metalloproteinase-3) at the start of bleeding episodes in levonorgestrel-implant users. Hum Reprod 2000; 15(Suppl 3): 120-34.
25. Jones RL, Critchley HO. Morphological and functional changes in human endometrium following intrauterine levonorgestrel delivery. Hum Reprod 2000; 15(Suppl 3): 162-72.
26. Cunningham MA, Rondeau E, Chen X et al. Protease-activated receptor 1 mediates thrombin-dependent, cell-mediated renal inflammation in crescentic glomerulonephritis. J Exp Med 2000; 19: 455-62.
27. Jenkins AL, Howells GL, Scott E et al. The response to thrombin of human neutrophils: Evidence for two novel receptors. J Cell Sci 1995; 108: 3059-66.
28. Herkert O, Kuhl H, Sandow J et al. Sex steroids used in hormonal treatment increase vascular procoagulant activity by inducing thrombin receptor (PAR-1) expression: Role of the glucocorticoid receptor. Circulation 2001; 104: 2826-31.
29. Rogers PA, Lederman F, Plunkett D et al. Bcl-2, Fas and caspase 3 expression in endometrium from levonorgestrel implant users with and without breakthrough bleeding. Hum Reprod 2000; 15(Suppl 3): 152-61.
30. Rodriguez GC, Walmer DK, Cline M et al. Effect of progestin on the ovarian epithelium of macaques: Cancer prevention through apoptosis? J Soc Gynecol Invest 1998; 5: 271-6.
31. Tao XJ, Tilly KI, Maravei DV et al. Differential expression of members of the bcl-2 gene family in proliferative and secretory human endometrium: Glandular epithelial cell apoptosis is associated with increased expression of bax. J Clin Endocrinol Metab 1997; 82: 2738-46.
32. Vaskivuo TE, Stenback F, Karhumaa P et al. Apoptosis and apoptosis-related proteins in human endometrium. Mol Cell Endocrinol 2000; 165: 75-83.
33. Perino A, Quartararo P, Catinella E et al. Treatment of endometrial hyperplasia with levonorgestrel releasing intrauterine devices. Acta Eur Fertil 1987; 18: 137-40.
34. Popovici RM, Kao LC, Giudice LC. Discovery of new inducible genes in in vitro decidualized human endometrial stromal cells using microarray technology. Endocrinology 2000; 141: 3510-3.